DermaProbe™

DermaProbe is a device for detecting malignant melanoma and other skin related diseases.

 

DermaProbe uses non-invasive dual-spectroscopy in combination with Corpus' proprietary analysis algorithms and AI technology.

 

DermaProbe is currently in use at Swedish hospitals. 

 

DermaProbe is developed by Corpus.

About our business

Summary of Business and Competence

Melanoma and DermaProbe

Neuropathy, clinical summary

Press release: Corpus announces DermaProbe™.

Press release: Linköping University Hospital purchases second DermaProbe™.

To learn more about DermaProbe, feel free to contact us